Immuron Ltd
IMC•Health Care•Biotechnology•Last updated: Dec 25
About
Immuron Ltd is a biopharmaceutical company focused on the development and commercialization of oral immunotherapy products for the treatment of gut-mediated diseases. The Company operates primarily through its Travelan and Protectyn segments, which are designed to prevent and treat infections and inflammatory conditions of the gastrointestinal tract. Immuron's products are based on polyclonal antibodies that target specific pathogens and toxins in the gut.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- IMC
Related Shares
Investor Resources
Should you buy Immuron Ltd right now?
While IMC looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now